Repair and maintenance services of medical equipment

Tender description

Lease note this is not the start of a procurement process. A separate contract notice will be published to cover this requirement. Please see section II.2 for details. Please note this is not the start of a procurement process. A separate contract notice will be published to cover this requirement. Background: NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales. Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales (Bristol, London, Oxford, Leeds, Sheffield, Liverpool, Manchester, Birmingham, Plymouth, Cardiff and the Clatterbridge Cancer Centre). Each unit is led by a team of specialist medical and nursing staff prior to commencing a formal procurement process and to help inform strategy requirements, NHSBT would like to consult the market to establish the likely level of interest for the consumables and maintenance of therapeutic apheresis machines, to support provision of the following services (as the tender will be divided into 3 lots as follows): 1) Extracorporeal Photopheresis (ECP) performed on Therakos UK Ltd, (part of Mallinckrodt Pharmaceutical) Cellex machines at the following Therapeutic Apheresis Services (TAS) sites: Liverpool, Clatterbridge Cancer Centre, Manchester, Bristol, Cardiff, Oxford, London and Plymouth. 2) Therapeutic multi-functional apheresis collection and exchange procedures performed on Terumo BCT Optia machines at the following TAS sites: Liverpool, Leeds, Sheffield, Manchester, Birmingham, Bristol, Oxford and London. 3) Low Density Lipoprotein removal performed on Fresenius Medical Care (UK) Ltd. ART Universal machines at the following TAS sites: Bristol and Leeds. NHSBT TAS may invite those organisations who express an interest in this PIN to Supplier Engagement Meetings to be held in December 2020. Any interested organisations are required to express their interest to marta.drozdzowska@nhsbt.nhs.uk by 5 p.m. on Friday, 5 December 2020, including a brief overview/web link of what might be offered to meet the requirements above. If you do not respond by this date you aren’t excluded from taking part in the forthcoming tender, this date is to allow for optional supplier engagement meetings to be organised. Further information (e.g. the draft technical specification, award criteria, timescales etc) may be released, for consultation purposes only, to organisations who express an interest. Please note that all details are subject to change.